0.9723
price down icon6.51%   -0.0677
after-market 시간 외 거래: .98 0.0077 +0.79%
loading

Xilio Therapeutics Inc (XLO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
3.55%
17.49
18.13 17.36 20.12 23.53
Operating Income/Loss
3.55%
-17.49
-18.13 -17.36 -20.12 -23.53
Nonoperating Income/Loss
40.21%
0.284
0.475 0.613 0.761 0.88
Income/Loss From Continuing Operations Before Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Income/Loss From Continuing Operations After Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Net Income/Loss
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
135.87K%
27.91
0.0205 27.52 27.47 27.43
Basic Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Diluted Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
자본화:     |  볼륨(24시간):